Trial site
National Hospital Organization Kyushu Medical Center
- 22running trials
- 7closed trials
The trials here
What the 29 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Lupus (SLE)4 trials
- Coronary artery disease2 trials
- Dermatomyositis and polymyositis (myositis)2 trials
- Stroke2 trials
- Antiphospholipid syndrome1 trial
- Atrial fibrillation1 trial
- Bladder cancer1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Crohn's disease1 trial
- Follicular lymphoma1 trial
- and 7 more
- Phase
- Phase 319 trials
- Phase 26 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting10 trials
- Recruiting10 trials
- Completed7 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC10 trials
- Bayer2 trials
- Hoffmann-La Roche2 trials
- National Cancer Center Hospital East2 trials
- Pfizer2 trials
- and 11 more
Running trials
Recruiting
A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer
Recruiting
Recruiting
A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic Syndromes
Recruiting
A Study of E6742 in Participants With Systemic Lupus Erythematosus
Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Recruiting
Recruiting
Recruiting
Recruiting
Enrolling by invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Active, not recruiting
Recruiting
TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer
Active, not recruiting
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
Active, not recruiting
Active, not recruiting
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Lupus (SLE)2 recruiting
- Antiphospholipid syndrome1 recruiting
- Colorectal cancer1 recruiting
- Coronary artery disease1 recruiting
- Crohn's disease1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Follicular lymphoma1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
Closed trials
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
Completed
A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
Completed
Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)
Completed
Completed
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Site data: ClinicalTrials.govUpdated 19 Nov 2026